Lista de obras -

Accelerating clinical development of HIV vaccine strategies: methodological challenges and considerations in constructing an optimised multi-arm phase I/II trial design

artículo científico publicado en 2014

Body composition and adipokines changes after initial treatment with darunavir-ritonavir plus either raltegravir or tenofovir disoproxil fumarate-emtricitabine: A substudy of the NEAT001/ANRS143 randomised trial

artículo científico publicado en 2019

Bone mineral density and inflammatory and bone biomarkers after darunavir-ritonavir combined with either raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults with HIV-1: a substudy of the NEAT001/ANRS143 randomised trial

artículo científico publicado en 2015

ChatGPT and beyond with artificial intelligence (AI) in health: Lessons to be learned

artículo científico publicado en 2023

Cytokine and gene transcription profiles of immune responses elicited by HIV lipopeptide vaccine in HIV-negative volunteers

artículo científico publicado en 2013

Decreased HIV-specific T-regulatory responses are associated with effective DC-vaccine induced immunity

artículo científico publicado en 2015

Dendritic cell-based therapeutic vaccine elicits polyfunctional HIV-specific T-cell immunity associated with control of viral load

artículo científico publicado en 2014

Diabetes and cognitive decline in a French cohort of patients infected with HIV-1.

artículo científico publicado en 2015

Early CD4+ T Cell Responses Are Associated with Subsequent CD8+ T Cell Responses to an rAd5-Based Prophylactic Prime-Boost HIV Vaccine Strategy

artículo científico publicado en 2016

Ebola vaccine development: Systematic review of pre-clinical and clinical studies, and meta-analysis of determinants of antibody response variability after vaccination

article

Gene Expression Signatures Associated With Immune and Virological Responses to Therapeutic Vaccination With Dendritic Cells in HIV-Infected Individuals

article

Is the current use of ‘positivity’ thresholds meaningful for evaluating HIV-vaccine immunogenicity endpoints? ⬇️

artículo científico publicado el 15 de mayo de 2013

Methodological issues in the use of composite endpoints in clinical trials: examples from the HIV field

artículo científico publicado en 2010

No Positive Association between Vitamin D Level and Immune Responses to Hepatitis B and Streptococcus pneumoniae Vaccination in HIV-Infected Adults

artículo científico publicado en 2016

Optimization and evaluation of Luminex performance with supernatants of antigen-stimulated peripheral blood mononuclear cells.

artículo científico publicado en 2016

Recent developments in clinical trial designs for HIV vaccine research

artículo científico publicado en 2015

Systems Vaccinology Identifies an Early Innate Immune Signature as a Correlate of Antibody Responses to the Ebola Vaccine rVSV-ZEBOV.

artículo científico publicado en 2017

T Cell Immunogenicity, Gene Expression Profile, and Safety of Four Heterologous Prime-Boost Combinations of HIV Vaccine Candidates in Healthy Volunteers: Results of the Randomized Multi-Arm Phase I/II ANRS VRI01 Trial

artículo científico publicado en 2022

Targeting HIV-1 Env gp140 to LOX-1 Elicits Immune Responses in Rhesus Macaques

artículo científico publicado en 2016

Lista de obras de

Accelerating clinical development of HIV vaccine strategies: methodological challenges and considerations in constructing an optimised multi-arm phase I/II trial design

Body composition and adipokines changes after initial treatment with darunavir-ritonavir plus either raltegravir or tenofovir disoproxil fumarate-emtricitabine: A substudy of the NEAT001/ANRS143 randomised trial

Bone mineral density and inflammatory and bone biomarkers after darunavir-ritonavir combined with either raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults with HIV-1: a substudy of the NEAT001/ANRS143 randomised trial

ChatGPT and beyond with artificial intelligence (AI) in health: Lessons to be learned

Cytokine and gene transcription profiles of immune responses elicited by HIV lipopeptide vaccine in HIV-negative volunteers

Decreased HIV-specific T-regulatory responses are associated with effective DC-vaccine induced immunity

Dendritic cell-based therapeutic vaccine elicits polyfunctional HIV-specific T-cell immunity associated with control of viral load

Diabetes and cognitive decline in a French cohort of patients infected with HIV-1.

Early CD4+ T Cell Responses Are Associated with Subsequent CD8+ T Cell Responses to an rAd5-Based Prophylactic Prime-Boost HIV Vaccine Strategy

Ebola vaccine development: Systematic review of pre-clinical and clinical studies, and meta-analysis of determinants of antibody response variability after vaccination

Gene Expression Signatures Associated With Immune and Virological Responses to Therapeutic Vaccination With Dendritic Cells in HIV-Infected Individuals

Is the current use of ‘positivity’ thresholds meaningful for evaluating HIV-vaccine immunogenicity endpoints? ⬇️

Methodological issues in the use of composite endpoints in clinical trials: examples from the HIV field

No Positive Association between Vitamin D Level and Immune Responses to Hepatitis B and Streptococcus pneumoniae Vaccination in HIV-Infected Adults

Optimization and evaluation of Luminex performance with supernatants of antigen-stimulated peripheral blood mononuclear cells.

Recent developments in clinical trial designs for HIV vaccine research

Systems Vaccinology Identifies an Early Innate Immune Signature as a Correlate of Antibody Responses to the Ebola Vaccine rVSV-ZEBOV.

T Cell Immunogenicity, Gene Expression Profile, and Safety of Four Heterologous Prime-Boost Combinations of HIV Vaccine Candidates in Healthy Volunteers: Results of the Randomized Multi-Arm Phase I/II ANRS VRI01 Trial

Targeting HIV-1 Env gp140 to LOX-1 Elicits Immune Responses in Rhesus Macaques